Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
- Status
- UNKNOWN
- Phase
- NA
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Anlotinib Retrospective Study for Esophageal Cancer
- Status
- COMPLETED
- Phase
- N/A
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial
- Status
- UNKNOWN
- Phase
- PHASE2